It is contraindicated for use in patients with a personal or family history of medullary thyroid carcinoma and in those with multiple endocrine neoplasia type 2
The cumulative incidence was 6.7% for semaglutide versus 0.8% for the non-GLP-1 RA group over 36 months
Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Your doctor will start you on a low dose and slowly raise it if your body tolerates the medication
Eli Lilly is expected to present this data to the U.S
Reducing sugar intake is an essential part of a healthy lifestyle, as sustainable weight loss should stem from long-term lifestyle changes